Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 1,224,401	$ (60,917,018)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Changes in fair value of derivative liabilities	(5,241,000)	58,751,585
Shares issued in debt settlement agreements	70,315
Stock based compensation	544,934	248,561
Changes in operating assets and liabilities:
Prepaid expenses	47,409	(60,086)
Accounts payable and accrued liabilities	570,033	149,320
NET CASH USED IN OPERATING ACTIVITIES	(2,783,908)	(1,827,638)
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of shares, net of finders' fee		2,326,014
Repayment of promissory note	(25,000)
Proceeds from exercise of warrants		2,500,000
Finders' fee on exercise of warrants		(35,000)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(25,000)	4,791,014
INCREASE (DECREASE) IN CASH	(2,808,908)	2,963,376
CASH, BEGINNING OF PERIOD	6,576,564	141,944
CASH, END OF PERIOD	3,767,656	3,105,320
SUPPLEMENTAL SCHEDULE OF NON-CASH ACTIVITIES
Reclassification of accrued liability upon issuance of common shares relating to Dr. Glynn Wilson's compensation	$ 191,000
Accounts payable settled in common stock		231,000
Fair value of issuance of warrants in January and March 2015 financing		9,313,000
Issuance of additional warrants in May 28, 2015 transaction		6,133,000
Reclassification of Derivative Warrant Liabilities to Equity at Exercise Date		$ 4,245,000